Bellerophon Therapeutics, Inc.

BLPH · NASDAQ
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Assets
Cash & Equivalents$6,924$24,736$47,557$9,874
Short-Term Investments$405$0$0$0
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$234$723$523$508
Total Curr. Assets$7,563$25,459$48,080$10,382
Property Plant & Equip (Net)$186$930$1,673$2,426
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$300$0$300
Tax Assets$0$0$0$0
Other NC Assets$186$186$486$0
Total NC Assets$372$1,416$2,159$2,726
Other Assets$0$0$0$0
Total Assets$7,935$26,875$50,239$13,108
Liabilities
Payables$1,230$1,192$3,725$3,106
Short-Term Debt$203$752$704$1,316
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$3,968$3,108$6,004$3,162
Total Curr. Liab.$5,401$5,052$10,433$7,584
LT Debt$0$203$956$1,659
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$1$601$274
Total NC Liab.$0$204$1,557$1,933
Other Liabilities$0$0$0$0
Cap. Leases$203$955$1,660$2,317
Total Liabilities$5,401$5,256$11,990$9,517
Equity
Pref Stock$0$0$0$0
Common Stock$96$95$95$46
Retained Earnings-$252,078-$232,247-$214,491-$189,763
AOCI$0$0$0$0
Other Equity$254,516$253,771$252,645$193,308
Total Equity$2,534$21,619$38,249$3,591
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$7,935$26,875$50,239$13,108
Net Debt-$6,721-$23,781-$45,897-$6,899